| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 11/13/2003 | US20030211091 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/13/2003 | US20030211090 Isolation culture product; cell differentiation |
| 11/13/2003 | US20030211088 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
| 11/13/2003 | US20030211087 Separation of mixture; insertion a nucleic acid which codes fluorescent protein; gene expression; neuron progenitor cell |
| 11/13/2003 | US20030211083 Injectable microspheres for tissue construction |
| 11/13/2003 | CA2763666A1 Keratinocytes expressing exogenous angiogenic growth factors |
| 11/13/2003 | CA2493944A1 Isolation of target cells, capillaries and microorgans |
| 11/13/2003 | CA2485216A1 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders |
| 11/13/2003 | CA2484614A1 Cell-seeded extracellular matrix grafts |
| 11/13/2003 | CA2484425A1 Fusions of cytokines and tumor targeting proteins |
| 11/13/2003 | CA2484360A1 In vitro mutagenesis, phenotyping, and gene mapping |
| 11/13/2003 | CA2484258A1 Soya cell strains with high isoflavone content |
| 11/13/2003 | CA2484187A1 Human adipocyte cell populations and methods for identifying modulators of same |
| 11/13/2003 | CA2484182A1 Novel antibody binding tcr and tirc7 and its use in therapy and diagnosis |
| 11/13/2003 | CA2483996A1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 11/13/2003 | CA2483915A1 Vectors having both isoforms of b-hexosaminidase |
| 11/13/2003 | CA2483913A1 Vascularization enhanced graft constructs comprising basement membrane |
| 11/13/2003 | CA2483912A1 Alcam and alcam modulators |
| 11/13/2003 | CA2483683A1 Vascularization enhanced graft constructs |
| 11/13/2003 | CA2483660A1 Injectable chondrocyte implant |
| 11/13/2003 | CA2483659A1 Corneal endothelium-like sheet and method of constructing the same |
| 11/13/2003 | CA2483478A1 Factor vii or viia polypeptide variants |
| 11/13/2003 | CA2483050A1 Optimization of transgene expression in mammalian cells |
| 11/13/2003 | CA2483047A1 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 11/12/2003 | EP1361277A1 Optimization of transgene expression in mammalian cells |
| 11/12/2003 | EP1361276A1 Pro-urokinase mutants |
| 11/12/2003 | EP1361273A2 Interleukin-3 (IL-3) multiple mutation polypeptides |
| 11/12/2003 | EP1361272A1 Neuritin, a neurogene |
| 11/12/2003 | EP1361271A2 Isolated nonapeptide derived from MAGE-3 gene and presented by HLA-A1, and uses thereof |
| 11/12/2003 | EP1361270A2 Disruption of the REDK gene |
| 11/12/2003 | EP1361269A1 Delivery of gene products via mesangial cells expressing an exogenous gene |
| 11/12/2003 | EP1361268A1 Pax-5-deficient pro-B cells, methods of producing them and the use of such cells in human therapy |
| 11/12/2003 | EP1361267A2 Mesenchymal stem cells and their use |
| 11/12/2003 | EP1361266A1 Transplantation cell kits for re-myelination in nerve cells |
| 11/12/2003 | EP1361265A1 Method for fixing cultured tissue and artificial skin affixed thereby |
| 11/12/2003 | EP1360962A2 Interferon tau composition and methods of use |
| 11/12/2003 | EP1360498A2 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 11/12/2003 | EP1360496A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| 11/12/2003 | EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha |
| 11/12/2003 | EP1360331A2 Vector system used in screening active substances |
| 11/12/2003 | EP1360314A2 Chemically defined medium for cultured mammalian cells |
| 11/12/2003 | EP1360311A2 Membrane penetrating peptides and uses thereof |
| 11/12/2003 | EP1360310A2 A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes |
| 11/12/2003 | EP1360308A2 Concatemers of differentially expressed multiple genes |
| 11/12/2003 | EP1360307A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 11/12/2003 | EP1360304A2 Enzymes |
| 11/12/2003 | EP1360301A2 Genes involved in isoprenoid compound production |
| 11/12/2003 | EP1360299A2 The genome of a bifidobacterium |
| 11/12/2003 | EP1360297A2 Ragweed allergens |
| 11/12/2003 | EP1360296A2 Method for the production of plant seed with modified fibre content and modified seed coat |
| 11/12/2003 | EP1360295A2 Molecules for desease detection and treatment |
| 11/12/2003 | EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 11/12/2003 | EP1360291A2 Human polynucleotides and polypeptides encoded thereby |
| 11/12/2003 | EP1360287A1 Methods of modifying eukaryotic cells |
| 11/12/2003 | EP1360284A2 Recombinant proteinase k |
| 11/12/2003 | EP1360281A2 Regulation of human wee1-like serine/threonine protein kinase |
| 11/12/2003 | EP1360279A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 11/12/2003 | EP1360278A2 Lipase variants |
| 11/12/2003 | EP1360277A2 Multipotent o-2a progenitors from the neurohypophysis |
| 11/12/2003 | EP1360276A2 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses |
| 11/12/2003 | EP1360204A2 Test system for the development of therapeutic agents, in particular active compounds for the treatment of osteoporosis |
| 11/12/2003 | EP1360199A2 Treatment involving dkk-1 or antagonists thereof |
| 11/12/2003 | EP1360198A2 Novel polypeptides and nucleic acids encoded thereby |
| 11/12/2003 | EP1360197A2 Histidine phosphatase interacting protein with 240kd |
| 11/12/2003 | EP1359932A2 Tip39 polypeptides |
| 11/12/2003 | EP1359904A2 P27 prevents cellular migration |
| 11/12/2003 | EP1359883A2 (psi)(epsilon)rack peptide composition and method for protection against tissue damage due to ischemia |
| 11/12/2003 | EP1359797A1 Human sphingosine-1-phosphate phosphatase |
| 11/12/2003 | EP0994904B1 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 11/12/2003 | EP0897390B1 Human tumor necrosis factor delta and epsilon |
| 11/12/2003 | EP0815867B1 Cells for treating dementia |
| 11/12/2003 | EP0804163B1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 11/12/2003 | EP0773952B1 Interaction trap systems for detecting protein interactions |
| 11/12/2003 | CN1455817A Methods for replacement, translocation and stacking of DNA in eukaryotic genomes |
| 11/12/2003 | CN1455816A Rescue of canine distemper virus from CDNA |
| 11/12/2003 | CN1455813A Human myeloma cell line |
| 11/12/2003 | CN1455812A Bio-reactor devoce |
| 11/12/2003 | CN1454991A Method of increasing super rice yield applying transgene technique |
| 11/12/2003 | CN1454990A Human egg mother cell storage method |
| 11/12/2003 | CN1454989A Yeast genetically engineered strain expressing hrp gene and constructing method thereof |
| 11/12/2003 | CN1454902A Mitochondria creatinekinase antibody |
| 11/12/2003 | CN1127569C Method for mass production of antimicrobial peptide |
| 11/12/2003 | CN1127568C Fibroblast growth factor homologs |
| 11/12/2003 | CN1127567C Culture and production of in vitro plant cell with chitosan to replace exogenous plant hormone |
| 11/12/2003 | CN1127518C Preparation of recombinant factor  in protein free medium |
| 11/12/2003 | CN1127351C Method for inducing antigen-specific T cell tolerance |
| 11/12/2003 | CN1127343C Myoblast therapy for mammalian diseases |
| 11/12/2003 | CN1127288C Wound repair dressings and methods for their preservation |
| 11/11/2003 | US6646183 DNA encoding for a disease resistance gene from common bean and methods of use |
| 11/11/2003 | US6646117 Having endoribonuclease activity; inactivates the viral capsid protein gene by cleavage |
| 11/11/2003 | US6646116 Variant tax gene of bovine leukemia virus |
| 11/11/2003 | US6646109 Antibody that binds specifically; blocked by nicotine |
| 11/11/2003 | US6645947 Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins |
| 11/11/2003 | US6645937 Methods using persephin and related growth factors |
| 11/11/2003 | US6645933 Polypeptide that binds extracellular domain of human Flt4 receptor tyrosine kinase; genetic engineering; endothelial cell growth factors and genes |
| 11/11/2003 | US6645765 Plant regulatory sequences for control of gene expression |
| 11/11/2003 | US6645764 Neocartilage and methods of use |
| 11/11/2003 | US6645763 Immortalized bone marrow mesenchymal stem cell |
| 11/11/2003 | US6645762 Synthases |
| 11/11/2003 | US6645761 Use to enhance the expression of the encoded polypeptide in mammalian cells |